Liver decompensation: the yard stick that measures indications and adverse effects of human albumin infusion-Reference-Cited by-同舟云学术

Liver decompensation: the yard stick that measures indications and adverse effects of human albumin infusion

Published:2023-02-08 Issue:3 Volume:17 Page:770-772
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Tiwari Avinash^ORCID,Aziz Riffat Abdul^ORCID,Gattani Ramkishor^ORCID,Kumar Prajapati Sandeep^ORCID,Tripathi Riddhima^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-023-10483-3.pdf

Reference6 articles.

1. Bai Z, Wang L, Wang R, Zou M, Méndez-Sánchez N, Romeiro FG, et al. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Hepatol Int [Internet]. 2022 Sep 1 [cited 31 Oct 2022]; Available from. https://doi.org/10.1007/s12072-022-10374-z

2. American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med. 2004;170(11):1247–1259

3. China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, Portal AJ, Salles NB, Gilroy DW, O'Brien A, ATTIRE Trial Investigators. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384(9):808-817. https://doi.org/10.1056/NEJMoa2022166

4. Fagan A, Gavis EA, Gallagher ML, Mousel T, Davis B, Puri P, et al. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. J Hepatol. 2022;S0168–8278(22):03116

5. Jagdish RK, Maras JS, Sarin SK. Albumin in advanced liver diseases: the good and bad of a drug! Hepatology. 2021;74(5):2848–2862